ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
ACAD on Nasdaq
Shares outstanding
170,107,714
Price per share
$26.71
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
167,656,338
Total reported value
$3,576,602,165
% of total 13F portfolios
0%
Share change
-2,113,884
Value change
-$46,292,348
Number of holders
327
Price from insider filings
$26.71
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 12% $280,489,106 19,878,746 BlackRock, Inc. 31 Jan 2025
RTW INVESTMENTS, LP 4.2% -20% $152,464,142 -$33,311,249 7,144,524 -18% RTW Investments, LP 30 Sep 2025

As of 30 Sep 2025, 327 institutional investors reported holding 167,656,338 shares of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD). This represents 99% of the company’s total 170,107,714 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BAKER BROS. ADVISORS LP 25% 42,896,690 0% 6.6% $915,415,365
BlackRock, Inc. 12% 20,268,644 -1.9% 0.01% $432,532,865
VANGUARD GROUP INC 8.9% 15,179,371 -0.56% 0% $323,927,778
STATE STREET CORP 4.3% 7,255,476 +17% 0.01% $154,831,858
RTW INVESTMENTS, LP 4.2% 7,144,524 -21% 1.9% $152,464,142
GEODE CAPITAL MANAGEMENT, LLC 1.8% 3,132,644 +3.6% 0% $66,859,595
DIMENSIONAL FUND ADVISORS LP 1.6% 2,798,134 +17% 0.01% $59,711,574
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.5% 2,484,156 +311% 0.08% $53,011,889
Palo Alto Investors LP 1.5% 2,466,684 -3.8% 9.7% $52,639,037
BRAIDWELL LP 1.4% 2,378,655 1.5% $50,760,498
MARSHALL WACE, LLP 1.4% 2,358,881 +20% 0.06% $50,338,520
GOLDMAN SACHS GROUP INC 1.2% 2,102,450 +43% 0.01% $44,866,283
FIRST TRUST ADVISORS LP 1.1% 1,943,152 -20% 0.03% $41,466,863
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.97% 1,648,864 +390% 0.02% $35,186,758
CITIGROUP INC 0.93% 1,574,070 -5.6% 0.02% $33,590,654
FRED ALGER MANAGEMENT, LLC 0.92% 1,567,035 -34% 0.13% $33,440,527
D. E. Shaw & Co., Inc. 0.92% 1,561,161 -21% 0.03% $33,315,176
DEUTSCHE BANK AG\ 0.89% 1,522,200 +107% 0.01% $32,483,748
TANG CAPITAL MANAGEMENT LLC 0.88% 1,500,000 0% 1.2% $32,010,000
Point72 Asset Management, L.P. 0.87% 1,486,357 -53% 0.07% $31,718,857
MILLENNIUM MANAGEMENT LLC 0.87% 1,483,235 +2052% 0.02% $31,652,235
Pictet Asset Management Holding SA 0.86% 1,463,048 -7.7% 0.03% $31,214,589
RENAISSANCE TECHNOLOGIES LLC 0.85% 1,449,533 -6.3% 0.04% $30,933,034
NORTHERN TRUST CORP 0.77% 1,303,536 +0.07% 0% $27,817,459
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.71% 1,204,088 +1.2% 0% $25,695,238

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,450,225 $65,160,558 +$79,135 $26.71 32
2025 Q3 167,656,338 $3,576,602,165 -$46,292,348 $21.34 327
2025 Q2 169,807,590 $3,663,065,967 -$28,402,849 $21.57 308
2025 Q1 171,410,883 $2,847,553,365 +$139,123,402 $16.61 314
2024 Q4 162,841,758 $2,987,254,268 +$159,320,971 $18.35 292
2024 Q3 154,563,806 $2,377,701,697 -$123,998,639 $15.38 258
2024 Q2 161,195,738 $2,619,390,257 +$12,291,411 $16.25 265
2024 Q1 159,787,542 $2,953,979,014 -$59,935,243 $18.49 268
2023 Q4 560,215 $17,551,454 +$4,145,557 $31.31 3
2023 Q3 154,758,492 $3,225,305,553 -$78,765,363 $20.84 244
2023 Q2 156,954,935 $3,759,194,061 +$21,867,840 $23.95 229
2023 Q1 157,362,324 $2,961,588,513 +$53,588,342 $18.82 229
2022 Q4 155,617,197 $2,477,395,120 +$28,420,807 $15.92 219
2022 Q3 148,105,367 $2,423,292,810 +$23,470,572 $16.36 204
2022 Q2 149,989,177 $2,113,382,794 +$2,597,508 $14.09 224
2022 Q1 146,404,040 $3,547,060,125 -$24,587,035 $24.22 249
2021 Q4 147,772,564 $3,448,380,945 +$76,442,524 $23.34 234
2021 Q3 144,737,445 $2,404,684,227 -$86,102,937 $16.61 229
2021 Q2 147,857,728 $3,605,769,819 +$55,747,211 $24.39 235
2021 Q1 144,591,141 $3,730,307,677 -$222,398,025 $25.80 257
2020 Q4 147,100,691 $7,863,948,207 -$112,035,697 $53.46 296
2020 Q3 149,918,017 $6,183,452,550 -$100,755,681 $41.25 259
2020 Q2 152,566,605 $7,391,584,748 -$49,283,741 $48.47 291
2020 Q1 153,616,187 $6,487,929,410 +$187,100,341 $42.25 240
2019 Q4 149,176,836 $6,381,669,394 +$117,136,919 $42.78 268
2019 Q3 146,260,795 $5,264,979,974 +$305,388,963 $35.99 227
2019 Q2 138,167,128 $3,692,810,124 +$175,307,516 $26.73 193
2019 Q1 137,769,473 $3,699,077,593 -$504,210 $26.85 195
2018 Q4 139,133,391 $2,249,597,616 +$303,188,596 $16.17 173
2018 Q3 118,220,695 $2,454,530,088 +$122,407,650 $20.76 176
2018 Q2 116,880,555 $1,784,761,158 -$131,328,718 $15.27 178
2018 Q1 122,154,833 $2,744,874,235 +$37,745,440 $22.47 189
2017 Q4 119,959,795 $3,612,265,167 +$37,244,502 $30.11 204
2017 Q3 116,797,545 $4,400,657,149 -$40,652,465 $37.67 203
2017 Q2 117,940,535 $3,288,085,727 +$72,163,063 $27.89 195
2017 Q1 119,485,095 $4,107,785,889 +$169,104,990 $34.38 211
2016 Q4 119,942,754 $3,459,110,173 +$99,389,058 $28.84 214
2016 Q3 117,841,646 $3,747,670,757 +$216,639,428 $31.81 226
2016 Q2 110,439,270 $3,587,406,539 +$35,391,714 $32.46 222
2016 Q1 109,653,220 $3,065,299,226 +$337,913,933 $27.96 208
2015 Q4 97,377,894 $3,471,525,840 -$45,929,482 $35.65 207
2015 Q3 98,502,576 $3,257,410,567 +$12,919,647 $33.07 183
2015 Q2 97,402,557 $4,080,339,564 +$68,015,702 $41.88 186
2015 Q1 97,286,433 $3,170,725,843 +$38,282,883 $32.59 192
2014 Q4 96,242,104 $3,055,689,395 +$57,916,488 $31.75 180
2014 Q3 94,226,006 $2,333,141,119 -$12,881,565 $24.76 162
2014 Q2 95,048,115 $2,147,110,372 +$93,853,346 $22.59 158
2014 Q1 90,888,457 $2,210,531,887 +$190,170,941 $24.33 162